Wealthcare Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$669K Buy
2,633
+6
+0.2% +$1.4K 0.28% 74
2026
Q1
$642K Buy
2,627
+67
+3% +$15.6K 0.3% 65
2025
Q4
$530K Buy
2,560
+395
+18% +$78.1K 0.25% 79
2025
Q3
$402K Buy
2,165
+50
+2% +$8.57K 0.18% 101
2025
Q2
$323K Sell
2,115
-674
-24% -$104K 0.16% 105
2025
Q1
$463K Sell
2,789
-528
-16% -$82.6K 0.24% 70
2024
Q4
$480K Buy
+3,317
New +$514K 0.25% 60

Other funds holding JNJ

Wealthcare Capital Partners's JNJ Position: Q2 2026 in Review

Wealthcare Capital Partners increased its Johnson & Johnson (JNJ) stake by 0.23% in Q2 2026, buying an estimated $1.4K and bringing the position to 2,633 shares worth $669K. The position accounts for 0.28% of the portfolio, ranked #74.

Wealthcare Capital Partners first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Wealthcare Capital Partners held 2,633 shares of Johnson & Johnson worth $669K as of Q2 2026.
  • Wealthcare Capital Partners bought 6 Johnson & Johnson shares in Q2 2026, an estimated $1.4K.
  • Johnson & Johnson made up 0.28% of Wealthcare Capital Partners's portfolio in Q2 2026, its #74 holding.
  • Wealthcare Capital Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Wealthcare Capital Partners's 13F filing for Q2 2026, filed 9 Jul 2026.